D

Daewoong Co Ltd
KRX:003090

Watchlist Manager
Daewoong Co Ltd
KRX:003090
Watchlist
Price: 20 900 KRW -1.88% Market Closed
Market Cap: 854.6B KRW
Have any thoughts about
Daewoong Co Ltd?
Write Note

Relative Value

The Relative Value of one Daewoong Co Ltd stock under the Base Case scenario is 42 835.1 KRW. Compared to the current market price of 20 900 KRW, Daewoong Co Ltd is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
42 835.1 KRW
Undervaluation 51%
Relative Value
Price
D
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
83
Median 3Y
0.5
Median 5Y
0.5
Industry
2.5
Forward
0.4
vs History
66
vs Industry
40
Median 3Y
7
Median 5Y
9
Industry
21.9
Forward
10.5
vs History
53
vs Industry
47
Median 3Y
6
Median 5Y
6.5
Industry
16.5
vs History
vs Industry
22
Median 3Y
26.2
Median 5Y
15.2
Industry
23.6
vs History
73
vs Industry
63
Median 3Y
1
Median 5Y
1.1
Industry
2.1
vs History
44
vs Industry
85
Median 3Y
0.5
Median 5Y
0.6
Industry
2.6
Forward
0.6
vs History
49
vs Industry
82
Median 3Y
1
Median 5Y
1.1
Industry
5.2
vs History
53
vs Industry
48
Median 3Y
3.4
Median 5Y
4.2
Industry
13.3
Forward
4.6
vs History
58
vs Industry
44
Median 3Y
4.3
Median 5Y
5.5
Industry
16.6
Forward
6.2
vs History
34
vs Industry
47
Median 3Y
6.1
Median 5Y
6.3
Industry
15.6
vs History
vs Industry
28
Median 3Y
25.2
Median 5Y
21.6
Industry
19.1
vs History
61
vs Industry
77
Median 3Y
0.5
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Daewoong Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Daewoong Co Ltd
KRX:003090
854.6B KRW 0.5 6.9 3.8 4.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
KR
D
Daewoong Co Ltd
KRX:003090
Average P/E: 29.2
6.9
-27%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top